Since the founding of the Summit in 2015, the opening session has been dedicated to a series of off-the-record, in depth conversations with biotech CEOs. The Purposeful CEO Series focuses on the unique experience of being a biotech CEO and make-or-break events that define the success. Below are examples from this series of talks:
The Purposeful CEO – Fulfilling the Promise
A candid discussion with Lou Lange, Partner, Asset Management Ventures & Former CEO, CV Therapeutics about building and maintaining lasting relationships.
The Purposeful CEO – Fulfilling the Promise Through Company Transformation
A candid discussion with Athena Countouriotis, President & CEO of Turning Point Therapeutics.
The Purposeful CEO and The Art of Rebuilding a Company
Stephen Aselage, CEO of Retrophin, Inc. discusses how his team recovered and rebuilt the company after ousting Martin Shkreli as CEO.
The Purposeful CEO – Driving Innovation While Reaping The Rewards Of Biotech’s New Golden Age
A candid discussion of the lessons learned during the journey through the evolution of the biotech industry and successive leadership positions with Paul J. Hastings, President and CEO, Nkarta Therapeutics, Inc and former CEO of OncoMed Pharmaceuticals.
The Purposeful CEO – What Really Happened Behind the Scenes of the Sanofi Acquisition of Ablynx
A candid discussion with Edwin Moses, PhD, CEO of Ablynx NV.
The Purposeful CEO – Building a Biotech Company That Makes a Difference
An interview with Rich Heyman, PhD, Executive Chairman & Co-Founder, Metacrine Inc.; former CEO of Seragon & Aragon.
The Purposeful CEO – Growing Successful Biotechs that Deliver Transformational Therapeutics
A candid discussion with four European Biotech CEOs: Geoff McDonough, CEO of Generation Bio; Simon Moroney, CEO & Co-Founder, MorphoSys AG; Edwin Moses, PhD, CEO of Ablynx NV; and Denise Scots-Knight, CEO & Co-Founder, Mereo BioPharma Group plc.
The Purposeful CEO—Driving Innovation While Reaping The Rewards Of Biotech’s New Golden Age
A candid discussion of the lessons learned during the journey through the evolution of the biotech industry and successive leadership positions.
- Discussion Leader – Barbara Ryan, Partner and Head of Healthcare and Life Sciences Clermont Partners
- Paul J. Hastings, President and CEO, Nkarta Therapeutics, Inc and former CEO of OncoMed Pharmaceuticals
